ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Animal models"

  • Abstract Number: 393 • 2017 ACR/ARHP Annual Meeting

    The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis

    Izumi Kurata, Isao Matsumoto, Atsumu Osada, Hiroshi Ebe, Hoshimi Kawaguchi, Yuya Kondo, Hiroto Tsuboi and Takayuki Sumida, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Follicular helper T (Tfh) cell is a novel T cell subset which promotes follicular B cell activation, differentiation to plasma cell and antibody production.…
  • Abstract Number: 1319 • 2017 ACR/ARHP Annual Meeting

    TAS05567 Is a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor That Attenuates Disease Severity in Animal Models of Autoimmune Diseases

    Hiroaki Hayashi, Ryuusuke Kaneko, Manabu Tayama, Shunsuke Demizu, Daichi Akasaka, Hiroki Irie, Aki Kawagishi, Yoshio Ogino, Teruhiro Utsugi, Eiji Sasaki and Yoshikazu Iwasawa, TAIHO PHARMACEUTICAL CO., LTD., Tsukuba, Japan

    Background/Purpose: Spleen tyrosine kinase (Syk) is a non-receptor cytoplasmic tyrosine kinase. B-cell receptor (BCR) and Fc receptor-mediated syk signaling pathways lead to activation of several…
  • Abstract Number: 1794 • 2017 ACR/ARHP Annual Meeting

    Overexpression of Interleuk-22 Induces Expression of the Negative Immune-Regulator SOCS3 and Potently Reduces Collagen-Induced Arthritis in Mice

    Debbie M. Roeleveld1, Monique M. Helsen2, Birgitte Walgreen3, Elly Vitters2, Fons A.J. van de Loo2, Peter L. van Lent2, Wim B. van den Berg2, Peter M. van der Kraan2 and Marije I. Koenders2, 1Experimental Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 2Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 3Experimental, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: High interleukin-22 (IL-22) levels are detected in serum and synovial fluid of rheumatoid arthritis (RA) patients and have been shown to positively correlate with…
  • Abstract Number: 394 • 2017 ACR/ARHP Annual Meeting

    Female Tumor Necrosis Factor Transgenic Mice Have More Severe Arthritis Than Males and Supporessed Levels of Bifidobacterium Pseudolongum in Their Gut Microbiome

    Emily Wu1, Richard Bell2, Alex Grier3, Steven Gill4, Edward Schwarz5 and Homaira Rahimi6, 1Department of Immunology, Microbiology, and Virology, University of Rochester, Rochester, NY, 2Center for Musculoskelatal Research, University of Rochester, Rochester, NY, 3Rochester Genomics Center, University of Rochester, Rochester, NY, 4Genomics Research Center, University of Rochester, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) has an increased prevalence and severity in women compared to men, yet the underlying etiology of this sexual dimorphism is unknown.…
  • Abstract Number: 1320 • 2017 ACR/ARHP Annual Meeting

    TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Ameliorates Inflammation and Bone Erosion in Murine Model for Rheumatoid Arthritis

    Yohei Yoshiga1, Fumihito Hosoi1, Satoru Iguchi1, Ryuusuke Kaneko2, Yoshinori Nakachi1, Daichi Akasaka2, Kenji Tanaka2, Kazuhiko Yonekura2, Teruhiro Utsugi2, Eiji Sasaki2 and Yoshikazu Iwasawa2, 1TAIHO PHARMACEUTICAL CO., LTD., TSUKUBA, Japan, 2TAIHO PHARMACEUTICAL CO., LTD., Tsukuba, Japan

    Background/Purpose: The erosions of bone and cartilage are a cardinal feature of rheumatoid arthritis (RA) and associated with disease severity and poor functional outcome. Although…
  • Abstract Number: 1833 • 2017 ACR/ARHP Annual Meeting

    iRhom2 Deficiency Protects Fcgr2b-/- Lupus-Prone Mice from Kidney Damage By Modulating ADAM17-Dependent Shedding of TNF-α and EGFR Ligand

    Xiaoping Qing1, Yurii Chinenov2, Patricia M. Redecha3, Michael Madaio4, Priya Issuree5, David McIlwain6, Tak Mak7, Carl Blobel5 and Jane E. Salmon8, 1Program in Inflammation and Autoimmunity, Hospital for Special Surgery, New York, NY, 2Arthritis & Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 3Autoimmunity & Inflammation, Hospital for Special Surgery, New York, NY, 4Medicine, Medical College of Georgia, Augusta, GA, 5Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 6Department of Microbiology and Immunology, Stanford University, Stanford, CA, 7Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, Toronto, ON, Canada, 8Medicine/Rheumatology, Hospital of Special Surgery, New York, NY

    Background/Purpose: A disintegrin and metalloprotease 17 (ADAM17) controls ecto-domain shedding of TNFα and epithelial-growth factor ligands (EGFR) such as heparin-binding EGF (HB-EGF).  TNFa and HB-EGF…
  • Abstract Number: 396 • 2017 ACR/ARHP Annual Meeting

    Phospho-STAT1 Inhibition Is the Initial Step after Tofacitinib Treatment in Rabbits with Severe Chronic Synovitis

    Sandra Pérez-Baos, Paula Gratal, Juan Ignacio Barrasa, Ana Lamuedra, Gabriel Herrero-Beaumont and Raquel Largo, Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

    Background/Purpose: Tofacitinib (TOFA) is a Janus Kinase (Jak) inhibitor approved for the treatment of rheumatoid arthritis (RA) 1. It has recently been shown to selectively…
  • Abstract Number: 1323 • 2017 ACR/ARHP Annual Meeting

    Crucial Roles for Toll-like Receptor 9 in the Pathogenesis of Erosive Autoimmune Arthritis and during Osteoclastogenesis

    Anita Fischer1, Brigitte Meyer1, Birgit Niederreiter2, Erik Lönnblom3, Rikard Holmdahl4 and Günter Steiner2, 1Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria, 2Rheumatology, Medical University of Vienna, Vienna, Austria, 3Department of Medical Biochemistry & Biophysics, Karolinska Institute, Stockholm, Sweden, 4Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Release and insufficient removal of endogenous nucleic acids may be involved in triggering harmful autoimmune reactions important in the initiation of systemic autoimmune diseases…
  • Abstract Number: 1910 • 2017 ACR/ARHP Annual Meeting

    ERAP1 Deficiency Implicates Long Peptides in Protection from HLA-B27-Induced Experimental Spondyloarthritis

    Tri Tran1, Tejpal Gill1, Joshua R. Bennett1, Vance Holt1, Sohee Hong2, Joel Taurog3 and Robert Colbert1, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institutes of Arthritis and Muskuloskeletal and skin diseases, National Institutes of Health, Bethesda, MD, 3Dept Int Med-Rheum Dis Div, University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: Common endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) haplotypes influence the risk of developing axial spondyloarthritis (SpA) in HLA-B27-positive individuals, with loss-of-function and reduced expression…
  • Abstract Number: 398 • 2017 ACR/ARHP Annual Meeting

    An on-Demand Drug Delivery System for the Treatment of Inflammatory Arthritis

    Jing Yan1, Nitin Joshi2, Seth Levy2, Sachin Bhagchandani2, Kai Slaughter2, Nicholas Sherman1, Julian Amirault2, Xueyin He2, Tan Shi Rui2, Michael Valic2, Praveen Vemula3, Oscar Miranda2, Oren Levy2, Antonios Aliprantis4, Joerg Ermann1 and Jeffrey Karp2, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bangalore, India, 4Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Many types of inflammatory arthritis (IA) are treated with systemic therapy. In situations where only one or a few joints are active, intra-articular drug…
  • Abstract Number: 1324 • 2017 ACR/ARHP Annual Meeting

    Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction of hTNF-Transgenic Arthritis Mice

    Takafumi Mito1, Tomoyuki Mukai1, Shunichi Fujita1, Shoko Kodama1, Akiko Nagasu1, Teruki Sone2 and Yoshitaka Morita1, 1Department of Rheumatology, Kawasaki Medical School, Kurashiki, Okayama, Japan, 2Department of Nuclear Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan

    Background/Purpose: Angiotensin II (Ang II) is known to function on various organs including kidneys, adrenal glands as well as the nervous and cardiovascular systems through…
  • Abstract Number: 1929 • 2017 ACR/ARHP Annual Meeting

    Sustained Efficacy of Intra-Articular SB-061, a Novel Matrix Regulator Inspired By Aggrecan, in a Rat Model of Osteoarthritis

    Kate Stuart1, Julia Chen1, Sharmi Saha1, Harsha Kabra1, Athene Chan1, Kamal Egodoge1, Jennifer Oskins2, Chaohua Lin2, Morten Karsdal3, Mark Chambers2 and John Paderi1, 1Symic Bio, Emeryville, CA, 2Lilly Research Laboratories, Indianapolis, IN, 3Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: No therapy for osteoarthritis (OA) has yet to deliver both structural and symptomatic benefits. Symic is approaching this unmet clinical need with a novel…
  • Abstract Number: 399 • 2017 ACR/ARHP Annual Meeting

    Therapeutic Effect of Rosiglitazone-Mediated Dendritic Cells in Established Arthritis in Mice

    Jin Jung Choi1, Sang-Yoon Jung2, Kyung-Su Park3, Chong-Hyeon Yoon4 and Dae-Seog Lim5, 1Rheumatology, CHA University Medical Center at Bundang, Sungnam, Korea, Republic of (South), 2Internal Medicine, Bundang CHA Medical Center, Seongnam, Korea, Republic of (South), 3Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea, Republic of (South), 4Rheumatology, The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu, Korea, Republic of (South), 5Department of biotechnology, CHA University, Sungnam, Korea, Republic of (South)

    Background/Purpose: Rosiglitazone is a selective ligand for peroxisome proliferator-activated receptor-gamma (PPAR-γ), which is expressed by antigen presenting cells (APCs) and plays a fundamental role in…
  • Abstract Number: 1325 • 2017 ACR/ARHP Annual Meeting

    Immune Responses to Peptides Containing Homocitrulline or Citrulline in the DR4-Transgenic Mouse Model of Rheumatoid Arthritis

    Patrick Lac1, Sheri Saunders1, Elena Tutunea-Fatan1, Lillian Barra2, David Bell3 and Ewa Cairns2, 1Microbiology and Immunology, The University of Western Ontario, London, ON, Canada, 2Medicine, Microbiology and Immunology, The University of Western Ontario, London, ON, Canada, 3Medicine, The University of Western Ontario, London, ON, Canada

    Background/Purpose: Antibodies to proteins/peptides containing citrulline (commonly measured using cyclic citrullinated peptide, CCP2) are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with…
  • Abstract Number: 2056 • 2017 ACR/ARHP Annual Meeting

    Performance and Validity of Musculoskeletal Ultrasound in the Assessment of Synovial Inflammation in Experimental Acute Gout

    Raquel Largo1, Juan Pablo Medina2, Sandra Perez-Baos2, Victor Najera-Aleson2, Aranzazu Mediero2, Gabriel Herrero-Beaumont1 and Esperanza Naredo3, 1Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain, 2Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain, 3Rheumatology, Joint and Bone Research Unit, IIS-FJD, Hospital Universitario Fundación Jiménez Díaz., Madrid, Spain

    Background/Purpose: Musculoskeletal ultrasound (MS-US) has not been validated as a reliable technique to evaluate joint inflammation in an acute gout rabbit model. Rabbit has been…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology